Please assess the completion status of the following clinical trial:

Trial Title: A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion criteria:~-Participants diagnosed as Functional Dyspepsia according to Rome III criteria.~Exclusion criteria:~* Participants with neuropsychiatric disorder.~* Participants diagnosed with irritable bowel syndrome, inflammatory bowel disease and serious constipation.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rabeprazole 10 mg (Type: EXPERIMENTAL): None
- Rabeprazole 20 mg (Type: EXPERIMENTAL): None
- Rabeprazole 40 mg (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).